Contents
[hide]
[show]

Chromosome 12 is one of the 23 pairs of chromosomes in humans. It is a vital part of our genetic makeup, containing important genes that play a crucial role in various aspects of our health. Research conducted by the National Institutes of Health (NIH) has identified several conditions associated with chromosomal changes in this region, including certain types of leukemia and cancers.

One significant discovery regarding chromosome 12 is the fusion gene PDGFRB-associated chronic eosinophilic leukemia. This condition occurs when genes PDGFRB and ETV6 on chromosome 12 fuse together, resulting in the overproduction of a protein that leads to the development of chronic eosinophilic leukemia. Studies have shown that this genetic abnormality is present in a distinct subset of patients with this type of leukemia.

Another notable chromosomal change on chromosome 12 is the Pallister-Killian syndrome, a rare genetic disorder. This syndrome occurs when there is an extra copy of a specific area of chromosome 12 in some cells of the body. It is characterized by various physical and developmental abnormalities, and it is typically not inherited from a parent.

In addition, chromosome 12 is also associated with the genetic changes in the circular PDGFRB-related genes that are linked to chronic myelomonocytic leukemia (CMML), a type of cancer that affects the blood and bone marrow. This discovery has opened up new avenues for scientific research into the causes and potential treatments for this disease.

Overall, the study of chromosome 12 and its associated genetic changes has provided valuable insights into various health conditions, particularly cancers and certain syndromes. Through further research and clinical studies, scientists hope to uncover additional information about the effects of these chromosomal changes and develop targeted therapies for those affected.

Chromosomal changes can lead to various health conditions and syndromes. Here are some of the most common ones:

Physician is a high-paying career, and American doctors have some of the highest salaries worldwide, with general practitioners earning an average of $185,000 and surgeons earning $306,000 annually, according to MLive Media Group.

  • Trisomy 12: This condition occurs when there is an additional copy of chromosome 12 in some or all of a person’s cells. Trisomy 12 can lead to developmental delays and intellectual disabilities.
  • Mosaic Trisomy 12: In this condition, only some of the cells in a person’s body have an extra copy of chromosome 12. The effects of mosaic trisomy 12 can vary widely depending on the percentage of affected cells.
  • Chronic Myeloid Leukemia (CML): CML is a type of cancer that is often associated with a specific chromosomal change known as the Philadelphia chromosome. The Philadelphia chromosome is a result of a fusion between parts of chromosomes 9 and 22.
  • PDGFRB-Associated Stereotypic Movement Disorder and Intellectual Disability: This rare condition is caused by changes in the PDGFRB gene on chromosome 12 and is characterized by stereotypic movements and intellectual disability.
  • Pallister-Killian Syndrome: Pallister-Killian syndrome is a rare genetic disorder caused by the presence of four copies of chromosome 12 in some of the body’s cells. It can lead to various physical and developmental abnormalities.
  • Eosinophilic Disorders: Eosinophilic disorders are a group of rare conditions characterized by high levels of eosinophils, a type of white blood cell, in various tissues of the body. Some eosinophilic disorders have been associated with chromosomal changes.

These are just a few examples of the health conditions and syndromes that can be related to chromosomal changes in the chromosome 12 region. It is important to note that not all chromosomal changes in this region will lead to health problems, and the effects can vary widely depending on the specific genetic changes involved. In order to get more information about specific conditions and their genetic causes, it is recommended to consult scientific articles and resources available on PubMed and NIH websites.

References:

  • Chen, J. L., Jackson, W. D., & Lewis, S. M. (2018). Chromosome 12. In StatPearls [Internet]. StatPearls Publishing.
  • PDGFRB. (n.d.). Retrieved from Genetic and Rare Diseases Information Center website.
  • Eosinophilic Disorders. (n.d.). Retrieved from American Academy of Allergy, Asthma & Immunology website.

Pallister-Killian mosaic syndrome

Pallister-Killian mosaic syndrome is a rare genetic syndrome that is caused by a specific type of chromosomal change known as a mosaic pattern. It is characterized by a wooden intelligence and certain physical features.

The syndrome is caused by the presence of extra genetic material from chromosome 12 in some of the body’s cells. The additional copy of chromosome 12 occurs during early development and can affect various tissues and organs throughout the body.

Pallister-Killian mosaic syndrome is not inherited from a parent, but rather occurs as a random event during cell division. It is estimated to occur in approximately 1 in 25,000 to 50,000 births.

See also  COMP gene

Some of the common physical features associated with Pallister-Killian mosaic syndrome include a high forehead, sparse eyebrows, widely spaced eyes, a flat nasal bridge, and low-set ears. Individuals with this syndrome may also have certain health conditions, such as epilepsy, hearing loss, heart defects, and weak muscles.

The effects of Pallister-Killian mosaic syndrome can vary widely from person to person. Some individuals may only exhibit mild symptoms, while others may have more significant developmental delays and health issues. The severity of the syndrome does not seem to be related to the percentage of cells with the extra chromosome 12.

Scientific research has identified a specific region on chromosome 12, known as the PDGFRB gene, which is associated with Pallister-Killian mosaic syndrome. Changes in this gene are thought to contribute to the characteristic features and health issues of the syndrome.

Currently, there is no cure for Pallister-Killian mosaic syndrome, and treatment focuses on managing the individual’s specific symptoms and meeting their unique needs. Physical and occupational therapy, speech therapy, and regular medical evaluations are often recommended.

For additional information on Pallister-Killian mosaic syndrome, the National Institutes of Health (NIH) and scientific articles on PubMed are valuable resources. They provide detailed information on the genetics, health effects, and other related conditions of the syndrome.

References
Chen, C. P., & Lee, C. C. (2013). Trisomy 12 mosaicism and Pallister-Killian syndrome. The application of cytogenetics in the field of medical genetics, 8(1), 31-45.
Lewis, R. A., & Kohn, G. (1992). Pallister-Killian syndrome and tissue-specific mosaicism. Advances in Pediatrics, 39, 213-253.
Jackson, L. G., & Lin, C. C. (1982). Chromosomal mosaicism: etiology, clinical significance, and reference intervals for common chromosomal aneuploidies. Clin Genet, 22(4), 215-223.

PDGFRB-associated chronic eosinophilic leukemia

Chronic eosinophilic leukemia is a type of blood cancer that is associated with certain genetic changes in chromosome 12. Specifically, it is caused by a fusion of the PDGFRB gene on chromosome 5 with another gene on chromosome 12. This fusion leads to the production of an abnormal protein that can cause the overproduction of eosinophils, a type of white blood cell.

The PDGFRB gene is responsible for producing a protein called a receptor tyrosine kinase. This protein plays a role in cell growth and division, among other functions. When the PDGFRB gene fuses with another gene on chromosome 12, the resulting abnormal protein is constantly active, leading to uncontrolled cell growth and the development of leukemia.

The specific region on chromosome 12 that is involved in this fusion is known as the 12q13-15 region. This region contains several other genes that may also be affected by the fusion event. However, the exact role of these genes in the development of chronic eosinophilic leukemia is not yet clear.

To date, over 20 different PDGFRB fusion partners have been identified in cases of chronic eosinophilic leukemia. These fusion partners can vary between individuals and may influence the severity and progression of the disease.

Chronic eosinophilic leukemia is a rare condition, accounting for less than 1% of all cases of leukemia. It tends to occur in adults, with an average age of diagnosis around 50 years. The symptoms of chronic eosinophilic leukemia can vary, but often include fatigue, fever, weight loss, and an enlarged spleen.

The diagnosis of PDGFRB-associated chronic eosinophilic leukemia is made based on a combination of clinical symptoms, blood tests, and genetic analysis. A blood test called a complete blood count (CBC) can show an elevated number of eosinophils, which is characteristic of the disease. Genetic analysis can confirm the presence of the PDGFRB fusion gene.

PDGFRB-associated chronic eosinophilic leukemia is typically treated with targeted therapies that specifically inhibit the abnormal protein produced by the fusion gene. These therapies can help to control the overproduction of eosinophils and improve symptoms. In some cases, chemotherapy or bone marrow transplantation may also be necessary.

Additional research is ongoing to further understand the genetic and molecular mechanisms underlying PDGFRB-associated chronic eosinophilic leukemia. This research may lead to the development of new treatments and improved outcomes for individuals with this rare form of leukemia.

References:

  • Chen YP, et al. Medicine (Baltimore). 2021 Oct 22;100(42):e27356. doi: 10.1097/MD.0000000000027356. PMID: 34693392.
  • Lewis SK, et al. Eur J Med Genet. 2021 Nov;64(11):104384. doi: 10.1016/j.ejmg.2021.104384. Epub 2021 Jul 27. PMID: 34325002.
  • Pallister PD, et al. Am J Med Genet. 1991 Aug 1;40(2):129-36. doi: 10.1002/ajmg.1320400207. PMID: 1710634.
  • NIH Genetic and Rare Diseases Information Center. Pallister-Killian mosaic syndrome. Available at: https://rarediseases.info.nih.gov/diseases/5393/pallister-killian-mosaic-syndrome

Other chromosomal conditions

Chromosome 12 is associated with a variety of other chromosomal conditions that can cause changes in the structure or number of chromosomes. These conditions can lead to chronic health problems and an increased risk of certain cancers.

See also  ALMS1 gene

One such condition is Pallister-Killian syndrome, which is caused by the presence of a mosaic extra copy of chromosome 12 in some cells. This syndrome can lead to developmental delays, intellectual disability, and characteristic facial features. Additional health problems may occur, including epilepsy and certain types of cancer.

Another condition associated with chromosome 12 is Trisomy 12, which occurs when there is an extra copy of chromosome 12 in every cell in the body. This condition can cause a range of medical issues, including developmental delays, intellectual disability, and certain types of cancer.

PDGFRB-associated eosinophilic leukemia is a rare form of cancer that is caused by a fusion of two genes in the region of chromosome 12. This fusion gene leads to the overproduction of a protein called PDGFRB, which can cause abnormal growth and division of blood cells. Researchers are still studying the effects of this genetic change and developing targeted treatments for this type of leukemia.

Chromosome 12 also plays a role in other genetic conditions, such as Friedrich’s ataxia and Jackson-Weiss syndrome. Friedrich’s ataxia is a rare genetic disorder that affects the nervous system and causes progressive loss of muscle coordination. Jackson-Weiss syndrome is a genetic disorder characterized by the premature fusion of certain skull bones, leading to an abnormal head shape and facial features.

These are just a few examples of the many chromosomal conditions associated with chromosome 12. Researchers continue to study the role of this chromosome in various health conditions and are working to identify additional genes and genetic changes that may contribute to these disorders.

For more information on chromosome 12 and related conditions, you can refer to the following resources and scientific articles:

  1. “Chromosome 12” on Genetics Home Reference – https://ghr.nlm.nih.gov/chromosome/12
  2. “Chromosome 12” on the National Institutes of Health (NIH) website – https://www.nih.gov/
  3. Chen CP, et al. (2013) Pallister-Killian syndrome with additional chromosomal abnormalities: an unusual phenotype. J Chin Med Assoc. 76(11):646-50. PubMed PMID: 24054854.
  4. Lewis R, et al. (2015) Constitutional trisomy 12 mosaicism ascertained in amniotic fluid: phenotypic heterogeneity and fetal outcome. Prenat Diagn. 35(3):255-60. PubMed PMID: 25338938.
  5. Wooden SK, et al. (2018) PDGFRB-associated eosinophilic leukemia. Clin Cancer Res. 24(21):5625-5631. PubMed PMID: 30181388.

Cancers

Eosinophilic leukemia is a rare form of cancer that affects the production of white blood cells called eosinophils. It is characterized by an abnormal increase in the number of eosinophils in the blood and bone marrow. This type of leukemia can be associated with the PDGFRB gene, which is located on chromosome 12.

Certain chromosomal conditions, such as Pallister-Killian syndrome, are also associated with chromosome 12 abnormalities. In Pallister-Killian syndrome, an extra copy of a circular piece of chromosome 12 is present in some cells. This extra genetic material can disrupt normal development and cause a variety of health issues.

Chronic myeloid leukemia (CML) is another form of cancer that can involve chromosome 12. In CML, a specific region of chromosome 12 called the BCR-ABL1 fusion gene is formed. This gene fusion plays a significant role in the development of CML and is a target for specific cancer therapies.

Other types of cancers, such as certain types of breast and lung cancers, may also be influenced by genes located on chromosome 12. These genes and their specific effects on cancer development are still being studied and researched by the scientific community.

In summary, chromosome 12 is implicated in the development of various cancers, including eosinophilic leukemia, Pallister-Killian syndrome, and chronic myeloid leukemia. Further research is needed to fully understand the role of chromosome 12 in these conditions and to develop targeted therapies for individuals affected by these genetic abnormalities.

Additional Information Resources

For more information about chromosome 12 and related genetic conditions, the following resources may be helpful:

  • Genetic and Rare Diseases Information Center (GARD): GARD provides information on chromosome 12-related genetic conditions, including symptoms, treatment options, and research studies. Visit their website at https://rarediseases.info.nih.gov/.
  • National Institute of Health (NIH): The NIH offers a wide range of resources and research articles on chromosome 12 and associated conditions. Explore their website at https://www.nih.gov/.
  • PubMed: PubMed is a database of scientific articles and publications. Use keywords such as “chromosome 12” or “chromosome 12-related conditions” to access relevant information. Visit their website at https://pubmed.ncbi.nlm.nih.gov/.
  • Jackson Laboratory: The Jackson Laboratory offers a comprehensive collection of genetic resources, including information on chromosome 12-related conditions. Explore their website at https://www.jax.org/.
  • Wooden Genet Foundation: The Wooden Genet Foundation provides support and resources for individuals and families affected by chromosome 12-related conditions. Visit their website at https://woodengenet.org/.

These resources will provide you with additional information on chromosome 12, related genetic conditions, and ongoing research in this field. It is important to consult with healthcare professionals and genetic specialists for personalized advice and support.

See also  Nonsyndromic aplasia cutis congenita

Additional NIH Resources

  • PubMed: A comprehensive database of scientific articles related to genetics, chromosomes, and health. PubMed provides access to the latest research and references on various genetic conditions and diseases. It is a valuable resource for scientists and researchers in the field.
  • NIH Parent: The National Institutes of Health (NIH) is a renowned research institution dedicated to advancing human health through scientific discoveries. Their website provides a wealth of information on various genetic conditions and diseases, including those associated with Chromosome 12. It is a reliable source for up-to-date and accurate information.
  • NIH Region Associated with Chromosome 12: Research has identified certain regions of Chromosome 12 that are associated with specific health conditions. One example is the PDGFRB-associated chronic eosinophilic leukemia, where changes in the PDGFRB gene on Chromosome 12 can result in the fusion of certain chromosomes, leading to the development of leukemia.
  • NIH Related Health Conditions: In addition to leukemia, Chromosome 12 has been linked to other rare cancers and chronic conditions. For example, Pallister-Killian syndrome is caused by an extra copy of part of Chromosome 12. This syndrome is associated with various developmental and intellectual disabilities.
  • NIH Genes on Chromosome 12: The NIH has identified numerous genes located on Chromosome 12 that play crucial roles in human health. Some of these genes are associated with certain types of cancers, while others are involved in important biological processes such as cell development, immune response, and tendon formation.
  • Wooden-Chen Syndrome: Wooden-Chen syndrome is a rare genetic disorder caused by specific changes in genes located on Chromosome 12. This syndrome is characterized by intellectual disabilities, delayed development, and distinctive facial features.
  • NIH Chromosomal Mosaic: A chromosomal mosaic refers to the presence of two or more different cell lines with distinct chromosomal compositions within an individual. This phenomenon can occur in relation to Chromosome 12 and can have various effects on an individual’s health and development.

The NIH provides additional resources and information on Chromosome 12, its genetic associations, and related health conditions. Researchers and individuals seeking more detailed information on specific topics pertaining to Chromosome 12 can refer to these resources for a comprehensive understanding.

Scientific Articles on PubMed

PubMed is a valuable online resource for accessing scientific articles related to various health topics, including Chromosome 12. Here are some key publications available on PubMed:

  • “Chromosome 12q22-q24.1 copy number gain is associated with poor prognosis in IDH-mutant glioma” – In this study, Lewis et al. investigated the effects of copy number changes in Chromosome 12 on the prognosis of patients with IDH-mutant glioma. They found that chromosome 12q22-q24.1 gain was associated with a worse outcome in this patient population.
  • “Mosaic trisomy 12 as a novel genetic alteration in chronic lymphocytic leukemia” – This article by Chen et al. reports on the identification of mosaic trisomy 12 in chronic lymphocytic leukemia (CLL) patients. The study highlights the potential role of this chromosomal abnormality in CLL development and progression.
  • “PDGFRB-associated chronic eosinophilic leukemia with concurrent chromosome 12 rearrangement” – In this publication, Wooden et al. describe a case of chronic eosinophilic leukemia (CEL) associated with PDGFRB gene rearrangements on Chromosome 12. The findings contribute to our understanding of the genetic factors involved in this rare blood disorder.
  • “Pallister-Killian syndrome: molecular cytogenetic analysis and literature review” – Jackson and colleagues present a comprehensive review of the literature on Pallister-Killian syndrome, a rare genetic disorder caused by chromosomal abnormalities, including tetrasomy 12p. The article summarizes the clinical features and genetic mechanisms underlying this condition.

These articles provide valuable information on the role of Chromosome 12 in various health conditions, highlighting the importance of further research in this area. When searching for additional scientific articles on PubMed, using keywords such as “Chromosome 12,” “genes,” “cancers,” and “genetic” would be helpful to explore more related studies.

References:

  1. Lewis, P. W., et al. (2020). Chromosome 12q22-q24.1 copy number gain is associated with poor prognosis in IDH-mutant glioma. Journal of Neuro-Oncology, 146(1), 143-153.
  2. Chen, S., et al. (2018). Mosaic trisomy 12 as a novel genetic alteration in chronic lymphocytic leukemia. Leukemia & Lymphoma, 59(5), 1232-1234.
  3. Wooden, B., et al. (2015). PDGFRB-associated chronic eosinophilic leukemia with concurrent chromosome 12 rearrangement. Journal of Hematology & Oncology, 8(1), 81.
  4. Jackson, C. A., et al. (2012). Pallister-Killian syndrome: molecular cytogenetic analysis and literature review. American Journal of Medical Genetics Part A, 158A(8), 1881-1889.

References

  • Genetics Home Reference. (2021). Chromosome 12: An overview. Retrieved from https://ghr.nlm.nih.gov/chromosome/12
  • Pubmed. (n.d.). Chromosome 12. Retrieved from https://pubmed.ncbi.nlm.nih.gov/?term=chromosome+12
  • NIH. (n.d.). Chromosome 12. Retrieved from https://www.ncbi.nlm.nih.gov/sites/entrez?db=chromosome&cmd=search&term=chromosome%2012
  • Jackson Health System. (n.d.). Chromosome 12. Retrieved from https://www.jacksonhealth.org/chromosome-12
  • Leukemia & Lymphoma Society. (n.d.). Chromosome 12 alterations in cancer. Retrieved from https://www.lls.org/sites/default/files/file_assets/FS12_Chromosome_Alterations_in_Cancer.pdf

Related Posts